Single-Dose Safety and Pharmacokinetics of ST-246, a Novel Orthopoxvirus Egress Inhibitor

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2008-03-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1128/AAC.01303-07PMID 18316519PMCID PMC2346641
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• N-(3,3a,4,4a,5,5a,6,6a-Octahydro-1,3-dioxo-4,6- ethenocycloprop[f]isoindol-2-(1H)-yl)carboxamides: Identification of novel orthopoxvirus egress inhibitors.

  2007cited by this paper
• Efficacy of the antipoxvirus compound ST-246 for treatment of severe orthopoxvirus infection.

  2007cited by this paper
• Efficacy of Delayed Treatment with ST-246 Given Orally against Systemic Orthopoxvirus Infections in Mice

  2006cited by this paper
• An Orally Bioavailable Antipoxvirus Compound (ST-246) Inhibits Extracellular Virus Formation and Protects Mice from Lethal Orthopoxvirus Challenge

  2005cited by this paper
• Smallpox DNA Vaccine Protects Nonhuman Primates against Lethal Monkeypox

  2004cited by this paper
• Smallpox vaccination: a review, part II. Adverse events.

  2003cited by this paper
• Can postexposure vaccination against smallpox succeed?

  2003cited by this paper
• Pathogenesis and potential antiviral therapy of complications of smallpox vaccination.

  2003cited by this paper
• Smallpox: a potential agent of bioterrorism.

  2003cited by this paper
• Botulinum toxin as a biological weapon: medical and public health management.

  2001cited by this paper
• Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.

  1999cited by this paper
• Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.

  1999cited by this paper
• Inhibitory effect of furanonaphthoquinone derivatives on the replication of Japanese encephalitis virus.

  1998cited by this paper
• Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH.

  1997cited by this paper
• Smallpox and its eradication

  1988cited by this paper

• Nonhuman primates as valuable models for mpox drug and vaccine discovery

  2025cites this paper
• An Overview of Antivirals against Monkeypox Virus and Other Orthopoxviruses.

  2023cites this paper
• Clinical considerations on monkeypox antiviral medications: An overview

  2023cites this paper
• Safety and Pharmacokinetics of the Substance of the Anti-Smallpox Drug NIOCH-14 after Oral Administration to Laboratory Animals

  2023cites this paper
• TECOVIRIMAT: A COMPREHENSIVE REVIEW OF NOVEL DRUG FOR MONKEYPOX DISEASE

  2023cites this paper
• Challenges in the treatment and prevention of monkeypox infection; A comprehensive review

  2023cites this paper
• Pharmacokinetic of Tecovirimat in subjects with Mpox.

  2023cites this paper
• New challenges in human monkeypox outside Africa: A review and case report from Italy

  2022cites this paper
• An Update on the Pharmacological Aspects of Vaccines and Antivirals for the Management of Monkeypox

  2022cites this paper
• A PBPK Model of Ternary Cyclodextrin Complex of ST-246 Was Built to Achieve a Reasonable IV Infusion Regimen for the Treatment of Human Severe Smallpox

  2022cites this paper
• The land-scape of immune response to monkeypox virus

  2022cites this paper
• Therapeutic strategies for human poxvirus infections: Monkeypox (mpox), smallpox, molluscipox, and orf

  2022cites this paper
• Monkeypox Virus Infections in Humans

  2022cites this paper
• New Perspectives on Antimicrobial Agents: Tecovirimat for Treatment of Human Monkeypox Virus

  2022cites this paper
• Monkeypox—What Pediatricians Need to Know

  2022cites this paper
• Monkeypox: A Comprehensive Review

  2022cites this paper
• Neurologic Complications of Smallpox and Monkeypox: A Review.

  2022cites this paper
• A brief on new waves of monkeypox and vaccines and antiviral drugs for monkeypox

  2022cites this paper
• Management of patients with monkeypox virus infection and contacts in the community and in healthcare settings: a French position paper

  2022cites this paper
• A Glance at the Development and Patent Literature of Tecovirimat: The First-in-Class Therapy for Emerging Monkeypox Outbreak

  2022cites this paper
• Therapeutic strategies to address monkeypox

  2022cites this paper
• Monkeypox in humans: a new outbreak

  2022cites this paper
• A human recombinant analogue to plasma-derived vaccinia immunoglobulin prophylactically and therapeutically protects against lethal orthopoxvirus challenge

  2021cites this paper
• Catalytic, Asymmetric Dearomative Synthesis of Complex Cyclohexanes via a Highly Regio- and Stereoselective Arene Cyclopropanation Using α-Cyanodiazoacetates.

  2020cites this paper
• Drug Development against Smallpox: Present and Future

  2020cites this paper
• Asymmetric Intramolecular Dearomatization of Nonactivated Arenes with Ynamides for Rapid Assembly of Fused Ring System under Silver Catalysis.

  2020cites this paper
• An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications

  2020cites this paper
• Identification of anti-poxviral agents by high-throughput image-based screening

  2019cites this paper
• Review on Camel Pox: Epidemiology, Public Health and Diagnosis

  2019cites this paper
• Risk factors for communicable diseases in humanitarian emergencies and disasters: Results from a three-stage expert elicitation

  2019cites this paper
• Oral Tecovirimat for the Treatment of Smallpox

  2018cites this paper
• Tecovirimat: First Global Approval

  2018cites this paper
• Monkeypox Transmission, Need and Treatment of Humans with an Antiviral Drug

  2017cites this paper
• The French Armed Forces Virology Unit: A Chronological Record of Ongoing Research on Orthopoxvirus

  2017cites this paper
• Further supramolecular chemistry of fused [n] polynorbornanes in solution and solid-state.

  2017cites this paper
• Orthopoxviruses—Plagues of Mankind, Strategists in Immune Evasion, Teachers in Vaccination

  2015cites this paper
• Orthopoxvirus : variole et vaccine

  2014cites this paper
• Co-administration of the broad-spectrum antiviral, brincidofovir (CMX001), with smallpox vaccine does not compromise vaccine protection in mice challenged with ectromelia virus

  2014cites this paper
• Antiviral options for biodefense.

  2013cites this paper
• Increased susceptibility of Cantagalo virus to the antiviral effect of ST-246®.

  2013cites this paper
• Safety and Pharmacokinetics of the Anti-Orthopoxvirus Compound ST-246 following a Single Daily Oral Dose for 14 Days in Human Volunteers

  2012cites this paper
• Deletion of the vaccinia virus F13L gene results in a highly attenuated virus that mounts a protective immune response against subsequent vaccinia virus challenge.

  2012cites this paper
• Pharmacokinetic Comparison of a Single Oral Dose of Polymorph Form I versus Form V Capsules of the Antiorthopoxvirus Compound ST-246 in Human Volunteers

  2012cites this paper
• [Necrotic skin lesions caused by pet rats in two teenagers].

  2011cites this paper
• Inhibition of poxvirus spreading by the anti-tumor drug Gefitinib (Iressa).

  2011cites this paper
• Lésions cutanées nécrotiques liées au Cowpox virus inoculé par des rats de compagnie

  2011cites this paper
• Breaking the Deadlock Over Destruction of the Smallpox Virus Stocks

  2011cites this paper
• Severe ear chondritis due to cowpox virus transmitted by a pet rat.

  2011cites this paper
• Development of the small-molecule antiviral ST-246 as a smallpox therapeutic.

  2011cites this paper
• SP600125 inhibits Orthopoxviruses replication in a JNK1/2 -independent manner: Implication as a potential antipoxviral

  2011cites this paper
• Comparison of the Safety and Pharmacokinetics of ST-246® after IV Infusion or Oral Administration in Mice, Rabbits and Monkeys

  2011cites this paper
• Safety and Pharmacokinetics of the Antiorthopoxvirus Compound ST-246 following Repeat Oral Dosing in Healthy Adult Subjects (cid:1)

  2010cites this paper
• Inhibition of poxvirus growth by Terameprocol, a methylated derivative of nordihydroguaiaretic acid.

  2010cites this paper
• Principles of antidote pharmacology: an update on prophylaxis, post‐exposure treatment recommendations and research initiatives for biological agents

  2010cites this paper
• Camelpox: epidemiology, diagnosis and control measures

  2010cites this paper
• Anti‐DNA Virus Agents

  2010cites this paper
• Tecovirimat, a p37 envelope protein inhibitor for the treatment of smallpox infection.

  2010cites this paper
• Polycyclic N‐Benzamido Imides with Potent Activity against Vaccinia Virus

  2010cites this paper
• Update on New Antivirals Under Development for the Treatment of Double‐Stranded DNA Virus Infections

  2010cites this paper
• Development of ST-246® for Treatment of Poxvirus Infections

  2010cites this paper
• Tecovirimat for smallpox infections.

  2010cites this paper
• Safety and Pharmacokinetics of the Antiorthopoxvirus Compound ST-246 following Repeat Oral Dosing in Healthy Adult Subjects

  2010cites this paper
• Impact of ST-246® on ACAM2000™ smallpox vaccine reactogenicity, immunogenicity, and protective efficacy in immunodeficient mice.

  2010cites this paper
• Nonhuman Primates Are Protected from Smallpox Virus or Monkeypox Virus Challenges by the Antiviral Drug ST-246

  2009cites this paper
• ST-246 Inhibits In Vivo Poxvirus Dissemination, Virus Shedding, and Systemic Disease Manifestation

  2009cites this paper
• Another ten stories in antiviral drug discovery (part C): “Old” and “new” antivirals, strategies, and perspectives

  2009cites this paper
• INTERET THERAPEUTIQUE DE LA PROTEINE A20 DES ORTHOPOXVIRUS COMME CIBLE PERTINENTE D'APTAMERES PEPTIDIQUES ET DE COMPOSES CHIMIQUES BLOQUANT SES INTERACTIONS ESSENTIELLES A L'INTERIEUR DU COMPLEXE DE REPLICATION VIRALE

  2009cites this paper
• Inhibition of Vaccinia Virus Replication by Two Small Interfering RNAs Targeting B1R and G7L Genes and Their Synergistic Combination with Cidofovir

  2009cites this paper
• ST-246 Antiviral Efficacy in a Nonhuman Primate Monkeypox Model: Determination of the Minimal Effective Dose and Human Dose Justification

  2009influential citation
• Efficacy of ST-246 versus lethal poxvirus challenge in immunodeficient mice

  2009cites this paper
• Therapeutic and prophylactic drugs to treat orthopoxvirus infections.

  2008cites this paper
• Emerging antiviral drugs

  2008cites this paper
• Specific Targeting of the F13L Protein by St-246 Affects Orthopoxvirus Production Differently

  2008cites this paper
• Progress in the Discovery of Compounds Inhibiting Orthopoxviruses in Animal Models

  2008cites this paper